Agilent Offers New Bio-SEC System for Biopharmaceutical Industry
Agilent’s Infinity range of LC systems have a latest addition in the form of new 1260 Infinity Multi-Detector Bio-SEC solution for biopharmaceutical industry. This new size exclusion chromatography (SEC) system is a state of the art, completely bio-inert, high resolution system with high sensitivity for protein aggregate analysis.
This new system offers highly reproducible, accurate information regarding the identity, purity and stability of biomolecules and mAbs, essential for characterizing them. Agilent 1260 Infinity Multi-Detector Bio-SEC system is completely bio-inert with high resolution columns, highly sensitive detector and an intuitive software which makes it easier for people with varying degrees of expertise to operate the system and analyse data thus generated with great ease.
The highly sensitive detector in the system measures static and dynamic light scattering pattern around the low volume bio-inert flow cell to produce accurate molecular weight data and size of the biomolecules respectively. The system has an excellent signal to noise ratio and it is ideal for use in biopharmaceutical and biotherapeutics industries where it is very important to conduct protein sizing, aggregates and bio-conjugate studies during each step of drug discovery and development to fully ensure the safety and efficacy of these compounds.
Using Agilent’s 1260 Infinity Multi-Detector Bio-SEC technology, the entire workflow of drug development lifecycle can be simplified by a huge scale to drastically reduce the time and expenses associated with bringing biopharmaceuticals into the market.
Source: Agilent
